Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: A 2-year study

G. Y. Tseng, H. J. Lin, C. T. Fang, H. B. Yang, G. C. Tseng, P. C. Wang, T. L. Hung, Y. C. Deng, Y. T. Cheng, C. H. Huang

研究成果: 雜誌貢獻文章同行評審

39 引文 斯高帕斯(Scopus)

摘要

Background: The role of Helicobacter pylori in the pathogenesis of peptic ulcer disease in patients with uraemia remains unclear. Aim: To evaluate the long-term effect of H. pylori eradication in these patients. Methods: Uraemic and non-uraemic patients with peptic ulcer were enrolled in this study. Patients having history of non-steroidal anti-inflammatory drugs use or cardiovascular disease that need aspirin use were excluded. After confirmation of H. pylori infection, they received a triple therapy and were followed up for 2 years. Results: Between September 1999 and December 2005, 34 patients (41%) of the end-stage renal disease [H. pylori (+) group] and 67 (84%) of the non-uraemic patients with peptic ulcer disease (PU group) received anti-H. pylori therapy. After triple therapy, 32 (94%) from the end-stage renal disease group and 64 (96%) from the peptic ulcer group obtained successful eradication. During the 2-year follow-up, three patients in the end-stage renal disease group were excluded because of the presence of cardiovascular disease and aspirin use in two cases and died of heart failure in one case; two patients in peptic ulcer group refused follow-up. Finally, 29 uraemic and 62 non-uraemic patients had achieved the follow-up. Recurrence of peptic ulcer was more in the end-stage renal disease group than in the peptic ulcer group with intention-to-treat analysis (eight of 32, 25% vs. two of 64, 3%, P = 0.001, OR: 10.0, 95% CI: 1.979-50.540) or per-protocol analysis (eight of 29, 28% vs. two of 62, 3%, P <0.001, OR: 11.4, 95% CI: 2.245-58.168). Conclusions: Peptic ulcer recurrence after H. pylori eradication is higher in end-stage renal disease patients with peptic ulcer than in peptic ulcer patients without renal disease. Factors aside from H. pylori play an important role in peptic ulcer recurrence in end-stage renal disease patients.

原文英語
頁(從 - 到)925-933
頁數9
期刊Alimentary Pharmacology and Therapeutics
26
發行號6
DOIs
出版狀態已發佈 - 九月 2007
對外發佈

ASJC Scopus subject areas

  • 藥學(醫學)
  • 藥理學、毒理學和藥劑學 (全部)

指紋

深入研究「Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: A 2-year study」主題。共同形成了獨特的指紋。

引用此